23 May 2017 - Policymakers are fiercely debating how to tackle the soaring costs of prescription drugs in Canada.
In a recent op-ed in the Toronto Star, Jamie Daw and Andrew Boozary suggested that the Canadian government should bundle purchase power for patented drugs in order to negotiate larger discounts. While their proposal would undoubtedly lower the price per dose, they miss key solutions that would provide faster, cheaper access to medication for the average Canadian.